Here Are Morgan Stanley's Key Oncology Catalysts for 2025

Seeking AlphaDec 28 23:31

Express News | Daiichi Sankyo's trastuzumab deruxtecan has been approved in Japan for the treatment of breast cancer.

BreakingsDec 28 08:54

Express News | The world's first batch! A potential blockbuster ADC has been approved for the treatment of breast cancer.

BreakingsDec 28 07:55

Daiichi Sankyo Gets Japanese Approval for Datroway

Seeking AlphaDec 27 23:52

Here's Why Astrazeneca (AZN) Is a Strong Value Stock

Yahoo FinanceDec 27 22:40

Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts

RTTNewsDec 27 15:12